Linkage Global Inc Ordinary Shares
Linkage Global Inc Ordinary Shares (LGCB) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Linkage Global Inc Ordinary Shares (LGCB), covering cash flow, earnings, and balance sheets.
Linkage Global Inc Ordinary Shares (LGCB) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Linkage Global Inc Ordinary Shares LGCB financial performance.
Metric | Q2 2024 | Q4 2023 | Q2 2023 |
---|---|---|---|
Revenue | $32380.00 | $3.70M | $9.03M |
Cost of Revenue | $27597.00 | $3.79M | $7.09M |
Gross Profit | $4783.00 | -$85244.00 | $1.95M |
Gross Profit Ratio | $0.15 | -$0.02 | $0.22 |
R&D Expenses | $2010.00 | $300137.00 | $287971.00 |
SG&A Expenses | $8948.00 | $980810.00 | $988689.00 |
Operating Expenses | $10957.00 | $1.28M | $1.28M |
Total Costs & Expenses | $38554.00 | $5.07M | $8.36M |
Interest Income | $0.00 | $6976.00 | -$4857.00 |
Interest Expense | $410.00 | $19108.00 | $83252.00 |
Depreciation & Amortization | $10.00 | $150285.00 | $113405.00 |
EBITDA | -$6164.00 | -$1.35M | $1.003M |
EBITDA Ratio | -$0.19 | -$0.33 | $0.09 |
Operating Income | -$6174.00 | -$1.37M | $669440.00 |
Operating Income Ratio | -$0.19 | -$0.37 | $0.07 |
Other Income/Expenses (Net) | -$403.00 | -$156357.00 | $136430.00 |
Income Before Tax | -$6577.00 | -$1.52M | $805869.00 |
Income Before Tax Ratio | -$0.20 | -$0.41 | $0.09 |
Income Tax Expense | -$516.00 | -$314992.00 | $251042.00 |
Net Income | -$6061.00 | -$1.21M | $554827.00 |
Net Income Ratio | -$0.19 | -$0.33 | $0.06 |
EPS | -$0.00 | -$0.06 | $0.03 |
Diluted EPS | -$0.00 | -$0.06 | $0.03 |
Weighted Avg Shares Outstanding | $21.50M | $20.00M | $21.50M |
Weighted Avg Shares Outstanding (Diluted) | $21.50M | $20.00M | $21.50M |
Financial performance has remained strong, with revenue growing from $9.03M in Q2 2023 to $32380.00 in Q2 2024. Gross profit continued to perform well, with margins at 15% in the latest quarter. Operating income reached -$6174.00 in Q2 2024, holding a steady -19% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$6164.00. Net income rose to -$6061.00, keeping EPS at -$0.00. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan